• Medical_Professionals
• Medical_students
• Nurses

It is a pleasure to invite you to participate in the 2nd European Congress on Tattoo and Pigment Research (ECTP2015), which will be held 29-30 April 2015 in Brugge, Belgium.

The 2nd ECTP congress held in Brugge in April 2015 is organised to present cutting edge research on tattoos and industrial pigments ranging from basic research to clinical research including health aspects and social sciences.

The congress invites chemists, biologists, physicists, toxicologists, formulation scientists, medical doctors including dermatologists and plastic surgeons, epidemiologists, sociologists and experts working with regulatory affairs to attend and to contribute with their presentations.

The research object tattoos, pigments, skin and health was neglected in the past. The 1st congress held in Copenhagen in November 2013 was a historical start up and establishment of a platform for achievements in recognition of the obvious knowledge and performance gap of the field relative to the fact that several millions of Europeans are tattooed with chemical substances and products of widely unknown specification, purity and sterility exposing them to uncertainty and risks. Such situation carries known and undiscovered hazardous health effects. The 2nd congress in Brugge follows up on the achievements in Copenhagen by offering an excellent scientific programme on the latest research in the field.

We look forward to welcoming you in Brugge!

Kind regards on behalf of the ESTP board and the Local Organising Committee

Congress Chairman: Christa De Cuyper, MD, Dermatology Department, AZ Sint-Jan, Brugge, Belgium

An Goossens , Prof. Department of Dermatology, University Hospital KU Leuven, Leuven, Belgium

Serge Coopman, MD, Skin & Laser Clinic, Antwerpen, Belgium

ESTP Board

Society Chairman: Jørgen Serup, Professor, DMSc, Bispebjerg University Hospital, Copenhagen, Denmark

Vice-chairman: Nicolas Kluger, MD, Montpellier University Hospital, Montpellier, France & University of Helsinki

Treasurer: Wolfgang Bäumler, Professor PhD.
University of Regensburg, Germany

Christa De Cuyper, MD,
Dermatology Department, AZ Sint-Jan, Brugge, Belgium

International Scientific Faculty

Jørgen Serup, Professor, DMSc, Bispebjerg University Hospital, Copenhagen, Denmark

Nicolas Kluger, MD,
Montpellier University Hospital, Montpellier, France & University of Helsinki  

Werner Aberer, Professor, Dr. med.
Medical University of Graz, Graz Austria

Maurice A. Adatto, MD,
Founder & Medical Director, SKINPULSE Dermatology, Laser & Beauty Centers, Geneva, Switzerland

Enzo Berardesca, MD, Professor,
Director Clinical Dermatology, San Gallicano Dermatological Institute, Rome, Italy

Wolfgang Bäumler, Professor PhD.
University of Regensburg, Germany

Christa De Cuyper, MD,
Dermatology Department, AZ Sint-Jarr, Brugge, Belgium

Ana M Giménez-Arnau, MD,
Hospital del Mar. Universitat Autònoma de Barcelona

Marléne Isaksson, DMSc, Associate Professor, 
Lund University, Malmoe, Sweden

Bo Jørgensen, Chief Surgion,
Bispebjerg University Hospital, Copenhagen, Denmark

Jana Kazandjieva, MD, PhD, Ass. Professor
Medical University, Sofia, Bulgaria. 

Moshe Lapidoth M.D, MPH.
Rabin Medical Center, Petach Tikva, Israel

Malinauskiena MD, DMSc,
Vilnius University, Antakalnio Hospital Alelrgy Center, Vilnius, Lithuania

EUR

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Submission Info

Important information

Do not include author names in the title or body of your abstract because a “blind” reviewing process will be used – you can enter the names online during the submission process.

• Product brand names are not allowed in the abstract title or abstract text. Use generic names only. A brand name can be inserted as a reference at the bottom of the abstract page.
• Abstracts submitted will be designated for either poster or oral presentations by the reviewing committee.

ABSTRACT SUBMISSION GUIDELINES

A. General conditions

• Abstracts are required for all oral presentations and posters.
• Abstracts must be submitted before 20 January 2015 (23:59 CET)
• Abstracts must be submitted in English
• Accepted abstracts will be published in the programme/abstract book and on the web page
• Withdrawal of abstracts can only be accepted if notified in writing and subsequently confirmed by the ECTP2015 Secretariat.  It is only possible to withdraw an abstract until 14 days after notification on acceptance.

B. Presenting author and registration

• The presenting author must register as an active participant at the congress at the latest 14 days after acceptance of an abstract.
• ECTP 2015 reserves the right to exclude any abstract that is not followed by a participant registration at the latest 14 days after notification of acceptance.

C. Contents of your abstract

• The abstract word limit is max. 250 words per abstract.
• The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end.
• No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract online.

The abstract must include the following:

Aim: Clearly state the purpose of the abstract.
Methods: Describe your selection of observations or experimental subjects clearly.
Results: Present your results in a logical sequence in text, table and illustrations.
Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them. 

• All abbreviations must be defined in first use.
• Statements such as “results will be discussed” or “data will be presented” cannot be accepted.

D. Reviewing

• The scientific committee will review the abstract.
• Notification of acceptance or rejection of the abstract will be sent to all authors by 15 February 2015.
• It is the responsibility of all investigators that all studies are performed with respect to national legislation, international legislation and ethical guidelines both with regards to humans and animals. The Scientific faculty of ECTP2015 reserves the right to reject any submitted abstract that is believed to violate these principles.
• Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.

ECTP2015 Sponsor and Exhibitor manual is available here. 

For further details and questions, please contact the congress secretariat.

If you have questions please contact:

ECTP 2015 Congress Secretariat

CAP Partner

info@cap-partner.eu

Tel: +45 7020 0305